SYNGAP1 Syndrome is a genetic disorder caused by a genetic mutation of the SYNGAP 1 gene, which interferes with the production of the protein of the same name, key to the effective communication of neurons. The first case was diagnosed in 2009 and it is estimated that worldwide there are between 1 and 4 cases per 10,000 people.<\/p>\n
The syndrome generates intellectual disability and developmental delay. Its symptoms are diverse and are not evident in all cases. Among the most obvious signs are:<\/p>\n
The diverse symptomatology of SYNGAP1 requires interdisciplinary work for its diagnosis and intervention, which is why it is necessary to link professionals in: Physiotherapy, Speech Therapy, Occupational Therapy, Psychology, Nutrition and Dietetics, Neurology, Genetics, among others.<\/p>\n
The Faculty of Health Sciences of the Mar\u00eda Cano University Foundation finds it pertinent to update and train students, professionals and the community in general, so that a deeper knowledge of SYNGAP1 is achieved and interventions with scientific rigor can be achieved and therefore This invites the academic community to join the Second Syngap 1 Scientific Congress to be held on September 23, online and in Spanish. The event is led and promoted by Syngap Research Fund. Those interested can register through the following link:<\/p>\n